- Home
- MRNA vs NUE Comparison
MRNA vs NUE Comparison
Compare MRNA & NUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | NUE |
|---|---|---|
| Founded | 2010 | 1905 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.6B | 58.6B |
| IPO Year | 2018 | 1994 |
Fundamental Metrics
Financial Performance| Metric | MRNA | NUE |
|---|---|---|
| Price | $154.25 | $249.74 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 11 |
| Target Price | $34.27 | ★ $209.60 |
| AVG Volume (30 Days) | ★ 23.7M | 1.1M |
| Earning Date | 05-01-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 1.01% |
| EPS Growth | ★ 21.77 | N/A |
| EPS | N/A | ★ 8.27 |
| Revenue | ★ $19,263,000,000.00 | N/A |
| Revenue This Year | $9.36 | $12.07 |
| Revenue Next Year | $15.43 | $4.14 |
| P/E Ratio | ★ N/A | $32.06 |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $22.28 | $131.32 |
| 52 Week High | $176.66 | $280.11 |
Technical Indicators
Market Signals| Indicator | MRNA | NUE |
|---|---|---|
| Relative Strength Index (RSI) | 64.57 | 43.20 |
| Support Level | $46.85 | $241.98 |
| Resistance Level | $156.42 | $268.01 |
| Average True Range (ATR) | 9.54 | 7.29 |
| MACD | -1.67 | -0.30 |
| Stochastic Oscillator | 78.72 | 9.39 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About NUE Nucor Corporation
Nucor Corp manufactures steel and steel products. The company's reportable segments are steel mills, steel products, and raw materials. The majority of its revenue is derived from the steel mills segment, which is engaged in producing sheet steel (hot-rolled, cold-rolled, and galvanized), plate steel, structural steel (wide-flange beams, beam blanks, H-piling, and sheet piling), and bar steel products. Nucor manufactures steel principally from scrap steel and scrap steel substitutes using electric arc furnaces (EAFs), along with continuous casting and automated rolling mills. The steel mills segment sells its products mainly to steel service centers, fabricators, and manufacturers located in the United States, Canada, and Mexico.